Effectiveness and Safety in Patients With Crohn´s Disease in Clinical Routine

A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

NCT02130362 ·Status: ACTIVE_NOT_RECRUITING

Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)

NCT00427921 ·Status: COMPLETED ·Phase: PHASE3

Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

NCT00409617 ·Status: COMPLETED ·Phase: PHASE3

Special Investigation in Patients With Crohn's Disease (All Patients Investigation)

NCT01298648 ·Status: COMPLETED

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

NCT00105300 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806

NCT00686374 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

NCT00409682 ·Status: COMPLETED ·Phase: PHASE3

Remission in Subjects With Crohn's Disease, 1 Year Phase

NCT00055497 ·Status: COMPLETED ·Phase: PHASE3

Remission in Subjects With Crohn's Disease, Open Label Extension

NCT01070303 ·Status: COMPLETED ·Phase: PHASE3

Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

NCT00077779 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

NCT02499783 ·Status: COMPLETED ·Phase: PHASE3

Adalimumab for the Management of Post-operative Crohn's Disease (CD)

NCT01629628 ·Status: UNKNOWN ·Phase: PHASE3

Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

NCT02015793 ·Status: COMPLETED ·Phase: PHASE2

TDM Guided Early Optimization of ADAL in Crohn's Disease

NCT03261102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

NCT00195715 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

NCT00055523 ·Status: COMPLETED ·Phase: PHASE2

Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)

NCT00338650 ·Status: COMPLETED ·Phase: PHASE3

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

NCT01848561 ·Status: ACTIVE_NOT_RECRUITING

Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants

NCT01562951 ·Status: TERMINATED ·Phase: PHASE3

Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)

NCT01960790 ·Status: COMPLETED

Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease

NCT02065570 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut

NCT01275508 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease

NCT01564823 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

NCT03464136 ·Status: COMPLETED ·Phase: PHASE3

Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

NCT01218360 ·Status: COMPLETED